MSP Recovery Inc (NASDAQ:LIFW) traded at $1.56 at close of the session on Monday, April 08, made an upward move of 19.08% on its previous day’s price.
Looking at the stock we see that its previous close was $1.31 and the beta (5Y monthly) reads -2.02 . In terms of its 52-week price range, LIFW has a high of $25.75 and a low of $0.65. The company’s stock has gained about 56.00% over that past 30 days.
MSP Recovery Inc has a market cap of $23.09 million.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $1.63 million, with a low of $303.98 million and a high of $303.98 million.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the LIFW stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is 83.87% off its SMA20 and 73.55% from its 50-day simple moving average. The RSI (14) is pointing at 78.80 while the volatility over the past week is 47.77% and jumps to 17.24% over the past one month. The beta value is -2.21, while the average true range (ATR) is currently pointing at 0.23.
Coming back to MSP Recovery Inc (NASDAQ:LIFW), we note that the average 3-month trading volume was 1.83 million, while that of the preceding 10-day period stands at 8.5 million. Current shares outstanding are 14.80 million.
The insiders hold 23.09% of the company’s shares while institutions hold 4.61%. The data shows that short shares as of Mar 15, 2024, stood at 0.35 million at a short ratio of 1.89. This represents a 2.39% short interest in shares outstanding on Mar 15, 2024. Shares short fall in March from the previous month at 0.66 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -31.28% down in year-to-date price movement.
